Diagnosis and Testing for River Blindness
Last updated:
River Blindness (onchocerciasis) is primarily diagnosed using Ov16 antibody blood tests and specialized slit-lamp eye exams that look for parasite larvae. Doctors also check travel history and may perform physical exams to find skin nodules or use skin snips and patch tests to confirm infection.
Key Takeaways
- • Doctors diagnose River Blindness using a combination of physical exams, blood tests, and specialized eye exams.
- • The Ov16 Rapid Diagnostic Test is a modern, quick blood test that checks for antibodies against the parasite.
- • An eye specialist can use a slit-lamp microscope to physically look for tiny baby worms in the front of the eye.
- • Skin snips and patch tests can detect parasites in the skin, but are used less frequently today than blood tests.
- • Patients exposed in Central or West Africa must be screened for the Loa loa parasite before starting treatment.
Diagnosing onchocerciasis (River Blindness) can be challenging because the symptoms often develop slowly and the number of parasites in your body can change over time [1][2]. Doctors use several different tests to look for either the physical presence of the worms or your body’s immune response to them [3][4].
Blood and Antibody Tests
Modern diagnosis often starts with blood tests that look for antibodies—proteins your immune system creates to fight the Onchocerca parasite [4]. These are now the preferred method in many areas [5].
- Ov16 Rapid Diagnostic Test (RDT): This is a quick finger-prick blood test, similar to a pregnancy test, that gives results in minutes [4][6]. It is affordable, painless, and very useful for screening large groups of people [6][5].
- Ov16 ELISA: This is a more detailed lab-based blood test [4]. While it takes longer, it is generally more sensitive than the RDT, meaning it is better at catching infections when the number of parasites is very low [4][6].
Physical and Eye Examinations
Because the worms live in the skin and can migrate to the eyes, physical exams are a critical part of the diagnostic process [3][7].
- Nodule Palpation: A doctor will feel your skin for onchocercomas—firm, painless lumps where adult worms often live [3][7]. These are usually found over bony areas like the hips or knees [8].
- Slit-Lamp Exam: An eye specialist uses a specialized microscope (slit lamp) to look for tiny baby worms (microfilariae) swimming in the clear front part of your eye [9][10]. During this exam, you may be asked to sit with your head tilted down for several minutes to help the larvae move into a position where they are easier to see [9].
Skin-Based Testing
Historically, looking at the skin was the only way to confirm an infection, but these methods are changing [11][1].
- Skin Snips: In this procedure, a small piece of skin (about the size of a grain of rice) is shaved off and examined under a microscope for baby worms [11]. While this was once the “gold standard,” it is used less often today because it is invasive and can miss infections if the parasite count is low [1][12].
- The DEC Patch Test: This is a modern version of the Mazzotti test [13]. A small patch containing the drug diethylcarbamazine (DEC) is placed on your skin [13]. If baby worms are present, they will die in that specific spot, causing a localized itchy reaction or rash within 24 hours [13].
Warning: In the past, patients were sometimes given DEC as a pill (the oral Mazzotti test) to see if it caused a full-body reaction. This is now considered dangerous and has been discontinued because it can cause severe, permanent damage to the eyes and other organs [14][15]. Furthermore, DEC should never be used as a treatment for River Blindness, avoiding any confusion with standard treatments for lymphatic filariasis.
Completeness Checklist
If you are being evaluated for River Blindness, you may receive one or more of the following:
- Travel/Exposure History: A detailed discussion of where you have lived or traveled [3].
- Physical Exam: Checking for nodules and skin changes like “leopard skin” [7][16].
- Blood Test: Either an Ov16 RDT or an ELISA [4].
- Specialized Eye Exam: A slit-lamp examination by an ophthalmologist [9].
- Loa loa Screening: If you were exposed in Central or West Africa, a blood test (often using a LoaScope) must be done to check for the Loa loa parasite before starting treatment [17][18].
- Molecular Testing (PCR): In some cases, a lab may use PCR to look for parasite DNA in skin or blood samples for the highest level of accuracy [19][20].
Frequently Asked Questions
How is River Blindness diagnosed using blood tests?
Do I need a skin snip to test for onchocerciasis?
What does an eye doctor look for during a slit-lamp exam?
What is the DEC patch test?
Why do I need to be screened for Loa loa before treating River Blindness?
Questions for Your Doctor
- • Which version of the Ov16 test are you using, and how accurate is it for my specific situation?
- • Is a skin snip necessary for my diagnosis, or can we rely on blood and eye exams?
- • Can you perform a slit-lamp exam to check for microfilariae in the front of my eye?
- • If we use a DEC patch test, what kind of skin reaction should I watch for over the next 24 hours?
- • Are there other infections, like Loa loa, that could interfere with my treatment plan, and should I be screened?
Questions for You
- • Have you recently taken ivermectin or other anti-parasitic medications, as these can make testing less accurate?
- • Do you have any painless lumps under your skin, particularly near your hips, ribs, or knees?
- • When you were in an area where the disease is common, were you bitten frequently by small black flies?
- • Have you noticed any new, intense itching that doesn't seem to have a clear cause?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities.
Thiele EA, Cama VA, Lakwo T, et al.
The American journal of tropical medicine and hygiene 2016; (94(4)):906-11 doi:10.4269/ajtmh.15-0695.
PMID: 26880774 - 2
Application of loop mediated isothermal amplification (LAMP) assays for the detection of Onchocerca volvulus, Loa loa and Mansonella perstans in humans and vectors.
Amambo GN, Innocentia N, Abong RA, et al.
Frontiers in tropical diseases 2023; (3()):1016176 doi:10.3389/fitd.2022.1016176.
PMID: 36684508 - 3
THE ARTHROPOD-BORNE ONCHOCERCIASIS: IS IT DESERVED TO BE NEGLECTED?.
El-Bahnasawy MM, Morsy AT, Morsy TA
Journal of the Egyptian Society of Parasitology 2015; (45(3)):639-54 doi:10.12816/0017932.
PMID: 26939243 - 4
Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo.
Hotterbeekx A, Perneel J, Mandro M, et al.
Pathogens (Basel, Switzerland) 2020; (9(6)) doi:10.3390/pathogens9060435.
PMID: 32498284 - 5
Usability, acceptability, and cost of the SD BIOLINE Ov16 rapid diagnostic test for onchocerciasis surveillance in endemic communities in the middle belt of Ghana.
Otabil KB, Basáñez MG, Ameyaa E, et al.
PLoS neglected tropical diseases 2025; (19(8)):e0012191 doi:10.1371/journal.pntd.0012191.
PMID: 40880542 - 6
Concordance between Ov16 Rapid Diagnostic Test(RDT) and Ov16 Enzyme-Linked Immunosorbent Assay (ELISA) for the Diagnosis of Onchocerciasis in Areas of Contrasting Endemicity in Cameroon.
Ekanya R, Beng AA, Anim MA, et al.
Parasite epidemiology and control 2023; (21()):e00290 doi:10.1016/j.parepi.2023.e00290.
PMID: 36875175 - 7
Onchocercoma of the scalp: A case report.
Savadogo I, Ido FAHA, Ouedraogo AS, Ouattara S
IDCases 2023; (33()):e01811 doi:10.1016/j.idcr.2023.e01811.
PMID: 37273776 - 8
Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch ME, Murdoch IE, Evans J, et al.
PLoS neglected tropical diseases 2017; (11(3)):e0005489 doi:10.1371/journal.pntd.0005489.
PMID: 28355223 - 9
A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO, Gyasi ME, Doe F, et al.
The American journal of tropical medicine and hygiene 2021; (106(2)):740-745.
PMID: 34844204 - 10
The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan.
Sube KL, Lako JDW, Tongun JB, et al.
Research and reports in tropical medicine 2024; (15()):111-121 doi:10.2147/RRTM.S481554.
PMID: 39735383 - 11
A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
Dana D, Debalke S, Mekonnen Z, et al.
BMC public health 2015; (15()):595 doi:10.1186/s12889-015-1888-x.
PMID: 26130117 - 12
Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.
Abong RA, Amambo GN, Chounna Ndongmo PW, et al.
BMC infectious diseases 2020; (20(1)):726 doi:10.1186/s12879-020-05444-2.
PMID: 33008333 - 13
Diagnosis of O. volvulus infection via skin exposure to diethylcarbamazine: clinical evaluation of a transdermal delivery technology-based patch.
Awadzi K, Opoku NO, Attah SK, et al.
Parasites & vectors 2015; (8()):515 doi:10.1186/s13071-015-1122-9.
PMID: 26452723 - 14
Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia.
Kanza EM, Nyathirombo A, Larbelee JP, et al.
Parasites & vectors 2024; (17(1)):137 doi:10.1186/s13071-023-06087-3.
PMID: 38491528 - 15
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
Budge PJ, Herbert C, Andersen BJ, Weil GJ
PLoS neglected tropical diseases 2018; (12(5)):e0006454 doi:10.1371/journal.pntd.0006454.
PMID: 29768412 - 16
Modelling of onchocerciasis-associated skin and ocular disease and the impact of ivermectin treatment.
Dixon MA, Ramani A, Walker M, et al.
Communications medicine 2026; doi:10.1038/s43856-026-01464-2.
PMID: 41766027 - 17
A Test-and-Not-Treat Strategy for Onchocerciasis Elimination in Loa loa-coendemic Areas: Cost Analysis of a Pilot in the Soa Health District, Cameroon.
Lenk EJ, Moungui HC, Boussinesq M, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (70(8)):1628-1635 doi:10.1093/cid/ciz461.
PMID: 31165855 - 18
Operationalization of the test and not treat strategy to accelerate the elimination of onchocerciasis and lymphatic filariasis in Central Africa.
Kamgno J, Nana-Djeunga HC, Pion SD, et al.
International health 2018; (10(suppl_1)):i49-i53 doi:10.1093/inthealth/ihx051.
PMID: 29471340 - 19
Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH, Moya L, Nguema J, et al.
Acta tropica 2018; (180()):12-17 doi:10.1016/j.actatropica.2017.12.030.
PMID: 29289559 - 20
O-5S quantitative real-time PCR: a new diagnostic tool for laboratory confirmation of human onchocerciasis.
Mekonnen SA, Beissner M, Saar M, et al.
Parasites & vectors 2017; (10(1)):451 doi:10.1186/s13071-017-2382-3.
PMID: 28969662
This page explains diagnostic testing for River Blindness (onchocerciasis) for educational purposes. Always consult an infectious disease specialist or ophthalmologist for proper medical evaluation and testing.
Stay up to date
Get notified when new research about Onchocerciasis is published.
No spam. Unsubscribe anytime.